Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04557059 |
Title | A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Prostate-Specific Membrane Antigen-Positron Emission Tomography (PSMA-PET) Positive Hormone-Sensitive Prostate Cancer Participants (PRIMORDIUM) |
Acronym | PRIMORDIUM |
Recruitment | Active, not recruiting |
Gender | male |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Janssen Pharmaceutica N.V., Belgium |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ITA | ESP | DEU | BEL | AUT | AUS |